2018 Annual Meeting Abstract Submission

60th Annual Meeting
December 10-14, 2018
Keystone Resort
Keystone, CO

You are invited to submit an abstract for the 60th Annual Meeting being held at the Keystone Resort in Keystone, CO from December 10-14, 2018. To submit an abstract, please read all of the instructions below.

Policies Governing Accepted Abstracts:

1.   Scientific Program is open to all Orthopaedic Surgeons and Residents/Fellows.
2.   Abstracts must be submitted online by June 15, 2018 to be eligible for review by the Program Committee.
3.   Submission of a corrected abstract is not allowed after June 1, 2018.
4.   An orthopaedic surgeon, resident/fellow or a member of SOMOS must be listed as one of the authors.
5.   Once an abstract is accepted, additional authors cannot be added and the abstract cannot be revised.
6.   Acceptance and rejection letters and all future correspondence will be emailed to the Primary Author listed on the Abstract Submission Form in August 2018. The complete scientific program and all presenters will be posted on the website. Failure to return Presenter Forms attached to the acceptance email, by the date listed, will result in the presentation being removed from the program.
7.   Abstracts not accepted for a podium presentation may be accepted for an E-Poster presentation.
8.   Withdrawing a presentation after acceptance will result in a 3 year probationary period. The primary author and co-authors will be unable to submit abstracts to SOMOS for consideration, unless there are reasonable extenuating circumstances.
9.   The abstract/paper is to be original, unpublished work.
10.   By October 1, 2018, the Primary Author will be required to submit a manuscript via email, to [email protected]. This is an absolute requirement to allow presentation of any study. Those that fail to submit by the published deadline may not be allowed to present their study. 
11.   SOMOS reserves the right to publish the accepted abstracts in a medical journal. This will not preclude publishing the manuscript in another journal.
12.   The Primary Author and all Co-authors will be required to complete a Disclosure Statement by October 15, 2018.
13.   All presenters will be required to complete and submit CME paperwork and adhere to all of the deadlines.
14.   SOMOS reserves the right to withdraw a presentation at any time.
15.   The Founder’s Award and the Norman T. Kirk Resident Award selection will be done prior to the Annual Meeting. Award winners will be notified via email prior to the meeting. The Louise House Award for poster presentations will be selected at the meeting.

Instructions for abstract content and completion of the abstract submission form:

1.   TITLE: Make the title brief and clearly indicate the nature of the study/procedure.
2.   AUTHOR’S NAME: Include rank and/or credentials.
3.   INSTITUTION WHERE THE STUDY/PROCEDURE TOOK PLACE: (Ex. University or Duty Base with City and State)
4.   CO-AUTHOR’S NAME: Include rank and/or credentials.
5.   CONTENT OF ABSTRACT: The abstract must include the following four parts:

INTRODUCTION, a sentence that clearly indicates the problem and the purpose of the study; 
METHODS, a brief description of pertinent experimental procedures;
RESULTS, a summary of the findings of the new unpublished study;
DISCUSSION and CONCLUSION, a statement of conclusions based upon the findings and related to the stated objective of the study and existing knowledge. 

Provide specific details about your research. DO NOT list any author's name or institution in the abstract or manuscript. A two-year minimum follow-up per patient is required for all results for reconstructive procedures and new or modified techniques as they relate to diagnosis, surgery, complications or other phases of orthopaedic surgical problems.

6.   LENGTH: Each abstract must be less than 650 words. Do not exceed space provided on abstract. Provide as much information as space permits. Additional pages will not be accepted. Graphs, charts, pictures, tables, etc., are not permitted. 
7.   TYPE: The abstract should be typed on the form provided within space allotted (650 words max). Use English only.
8.   STYLE: Use title case for the entire title.  DO NOT include company/industry names, titles, appointments or addresses in the abstract. DO NOT use subtitles. Standard abbreviations may be used, when necessary. Do not cite references. Do not include < or > signs within the abstract. No reference is to be made in your text as to authors, institutions, clinics, specific manufacturers or pharmaceutical companies. Please check your work prior to submission. SOMOS is not responsible for proofreading or accuracy.   
9.   AUTHOR INFORMATION: Indicate your name, mailing address, email address, telephone number, degree and the institution. Also, include the name, email address and degrees of all co-author(s). Please notify SOMOS if any of this information changes.
10.   DRUG NAMES: Nonproprietary (generic) names of drugs are required and should be written in lower case. Proprietary names are capitalized. Do not use company or product names in the title or body of the abstract.
11.   SUBMISSIONS: An Electronic Submission form is provided below for all submissions. The abstract submission deadline for the SOMOS 2018 Annual Meeting is June 15, 2018.
12.   NOTIFICATION OF ACCEPTANCE: The Program Committee will review Abstracts. You will be notified by email of acceptance in August 2018. SOMOS reserves the right to withdraw a paper at any time.
13.   REGISTRATION FEES: All presenters must register for the meeting.
14.   MANUSCRIPT: The paper is to be original, unpublished work. All authors must indicate the publication status of their paper. Papers that have been previously published are ineligible. A paper that has been submitted for publication, but will remain unpublished prior to the date of the Annual Meeting is eligible. The Program Committee has the right to withdraw the paper.

Abstract Grading Process

1.   Abstracts will be read in a “blind” fashion. Your text should not reveal the authors or institutions of origin.

2.   Graders are military orthopaedic surgeons and are members of the Program Committee or Panel Reviewed. The Program Chair/Committee uses some discretion in final paper selection in an attempt to balance the program. Abstracts are graded on a 0 to 10 rating, and a paper accepted generally will have an average score of 7.0.

3.   Grade is influenced by: significance of the study, content and clarity, specific number of cases or specimen studies, clinical or research data to support its conclusions, minimum follow-up of 2 years per patient for results describing reconstructive procedures, and new or modified techniques as they relate to diagnosis, surgery, complications or other phases of orthopaedic surgical problems.

Submission Agreement

  • All authors must agree to the following statements on the submission form for this abstract to be considered.
  • We, the listed authors on this abstract, submit this abstract for presentation consideration to SOMOS. We affirm that the information contained in this abstract fairly and accurately represents original work.
  • We agree that, if accepted for inclusion in a SOMOS meeting, the manuscript, published abstract and presentation will represent the same data as originally submitted herein.
  • We assume full responsibility for securing the necessary clearance and permission for publication and presentation from any contracting supervisory research agency holding presentation material copyrights. SOMOS requires that Podium Presenters, Co-Authors and all Poster Presenters provide their financial disclosure online.
  • We agree that any and all financial interest in the product or process involved with our research will be properly identified. This includes stock ownership, membership on an advisory board or board of directors, corporate sponsored research, or any other substantive relationship. Please note that financial disclosure does not disqualify an abstract from consideration or presentation.
  • We agree that disclosure will be made if a presentation includes substances or products not approved in the U.S. for the use under discussion.
  • We understand and grant release to SOMOS to make any recordings of our presentation. We authorize the recording of our presentation for any related purposes.
Submit your abstract today!